PNPLA3 and metabolic dysfunction-associated steatohepatitis: The landmark PNPLA3 study measured hepatic fat content by 1H-MRS and examined inflammation through serum levels of ALT to suggest that rs738409 could increase risk of NASH, but the study itself did not focus on histologic NASH or cirrhosis (97).